KERRY BROWN, MD
Ophthalmology Physician · ABBEVILLE, LA
Individual Active NPI 1306818612
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,091 | 10,892 | $3,591,570 | $996,514 | $748,183 |
| 2023 | 1,284 | 9,464 | $3,921,280 | $1,072,843 | $803,357 |
| 2022 | 1,346 | 7,122 | $4,619,380 | $1,187,859 | $895,395 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 5,160 | $35 | $27 |
| 92134 | Imaging of retina | 1,200 | $35 | $25 |
| 92014 | Established patient complete exam of visual system | 599 | $110 | $73 |
| 67028 | Injection of drug into eye | 562 | $99 | $75 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 515 | $115 | $64 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 490 | $14 | $10 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 479 | $81 | $54 |
| J0178 | Injection, aflibercept, 1 mg | 442 | $828 | $654 |
| J9035 | Injection, bevacizumab, 10 mg | 193 | $72 | $53 |
| 92250 | Photography of the retina | 169 | $31 | $21 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 169 | $22 | $15 |
| 92133 | Imaging of optic nerve | 142 | $32 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 16581 | LA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Louisiana
- NPI 1962582221
- NPI 1255428496
- NPI 1427038744
- NPI 1578543856
- NPI 1073550448
- NPI 1750316931
- NPI 1144418484
- NPI 1790994929
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.